CTOs on the Move

DAP Health

www.daphealth.org

 
DAP Health is a health center in Palm Springs, CA that provides medical and mental healthcare, STI testing and treatment, dentistry, pharmacy, and lab services. They also offer social services, support groups, alternative therapies, and other wellness ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Natural Partners

Natural Partners offers quality wholesale vitamins and supplements and a convenient way for health care practitioners to better serve their patients.

Citra Health

Citra is a health solutions company providing a one-contract, connected solution for clinical, financial and administrative requirements. Solving for the needs of providers, payers, health systems and employers in the transition to value-based care, Citra empowers clients with proven technology, population health, analytics, care management, and administrative services to strategically expand market opportunity, diversify revenue streams, and lower the cost of care and improve quality. Serving 6 of the top 7 Health Plans; 7 Fortune 500 Companies; 50+ IPAs and MSOs managing commercial, Medicare and Medicaid populations; 100+ Provider Groups, Hospitals, Universities and Integrated Delivery Networks throughout the United States and in Puerto Rico. Citra delivers technology and services resulting in more efficient operations and higher quality care. Our vision is for providers, health systems, payers, and employers to embrace the transformation of healthcare payment models using our cohesive clinical, financial and administrative solutions.ical, financial and administrative solutions.

SEIU 775 Benefits Group

Holistic training, health and retirement benefits for Washington states professional home caregivers.

Acusis

Acusis is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.